3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Hepatocellular
20
Neoplasm Metastasis
13
Liver Neoplasms
8
Colorectal Neoplasms
7
Lung Neoplasms
6
Cholangiocarcinoma
6
Pancreatic Neoplasms
5
Rectal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Barrett Esophagus
4
Recurrence
3
Pain
3
Biliary Tract Neoplasms
3
Prostatic Neoplasms
2
Leiomyoma
2
Kidney Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Thyroid Cancer, Papillary
1
Thymoma
1
Squamous Intraepithelial Lesions
1
Small Cell Lung Carcinoma
1
Pancreatic cancer, adult
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Neoplasm Micrometastasis
1
Myoma
1
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Radiofrequency Ablation
1
Prednisone
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Dexamethasone
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hyperaldosteronism
×
Radiofrequency Ablation
×
Clear all
NCT02756754
2026-05-04
ADERADHTA
University Hospital, Toulouse
Phase NA
Completed
31 enrolled